4.6 Article

Electroconvulsive seizure induces thrombospondin-1 in the adult rat hippocampus

Journal

Publisher

PERGAMON-ELSEVIER SCIENCE LTD
DOI: 10.1016/j.pnpbp.2013.10.001

Keywords

ECS; Glia; Mood disorder; Synaptogenesis; TSP-1

Funding

  1. JSPS KAKENHI [24790106]
  2. Grants-in-Aid for Scientific Research [24790106, 12J06852] Funding Source: KAKEN

Ask authors/readers for more resources

Synaptic dysfunction has recently gained attention for its involvement in mood disorders. Electroconvulsive therapy (ECT) possibly plays a role in synaptic repair. However, the underlying mechanisms remain uncertain. Thrombospondin-1 (TSP-1), a member of the TSP family, is reported to be secreted by astrocytes and to regulate synaptogenesis. We investigated the effects of electroconvulsive seizure (ECS) on the expression of TSPs in the adult rat hippocampus. Single and repeated ECS significantly increased TSP-1 mRNA expression after 2 h and returned to sham levels at 24 h. Conversely, the TSP-2 and -4 mRNA levels did not change. Only repeated ECS induced TSP-1 proteins. ECS also induced glial fibrillary acidic protein (GFAP) expression. The GFAP expression occurred later than the TSP-1 mRNA expression following single ECS; however, it occurred earlier and was more persistent following repeated ECS. ECS had no effect on the alpha 2 delta-1 or neuroligin-1 expressions, both of which are TSP-1 receptors. Furthermore, chronic treatment with antidepressants did not induce the expression of TSP-1 or GFAP. These findings suggest that repeated ECS, but not chronic treatment with antidepressants, induces TSP-1 expression partially via the activation of astrocytes. Therefore, TSP-1 is possibly involved in the synaptogenic effects of ECS. (C) 2013 Elsevier Inc. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Biochemistry & Molecular Biology

Tricyclic Antidepressant Amitriptyline-induced Glial Cell Line-derived Neurotrophic Factor Production Involves Pertussis Toxin-sensitive Gαi/o Activation in Astroglial Cells

Kazue Hisaoka-Nakashima, Kanako Miyano, Chie Matsumoto, Naoto Kajitani, Hiromi Abe, Mami Okada-Tsuchioka, Akinobu Yokoyama, Yasuhito Uezono, Norimitsu Morioka, Yoshihiro Nakata, Minoru Takebayashi

JOURNAL OF BIOLOGICAL CHEMISTRY (2015)

Article Biochemistry & Molecular Biology

Fibroblast growth factor 2 mRNA expression evoked by amitriptyline involves extracellular signal-regulated kinase-dependent early growth response 1 production in rat primary cultured astrocytes

Naoto Kajitani, Kazue Hisaoka-Nakashima, Mami Okada-Tsuchioka, Mayu Hosoi, Toshiki Yokoe, Norimitsu Morioka, Yoshihiro Nakata, Minoru Takebayashi

JOURNAL OF NEUROCHEMISTRY (2015)

Article Biochemistry & Molecular Biology

The expression of glial cell line-derived neurotrophic factor mRNA by antidepressants involves matrix metalloproteinase-9 activation in rat astroglial cells

Hiromi Abe, Kazue Hisaoka-Nakashima, Naoto Kajitani, Mami Okada-Tsuchioka, Ryoya Yano, Kei Itagaki, Chiyo Shibasaki, Norimitsu Morioka, Yoshihiro Nakata, Minoru Takebayashi

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2016)

Article Neurosciences

Amitriptyline induces brain-derived neurotrophic factor (BDNF) mRNA expression through ERK-dependent modulation of multiple BDNF mRNA variants in primary cultured rat cortical astrocytes and microglia

Kazue Hisaoka-Nakashima, Naoto Kajitani, Masahiro Kaneko, Takahiro Shigetou, Miho Kasai, Chie Matsumoto, Toshiki Yokoe, Honami Azuma, Minoru Takebayashi, Norimitsu Morioka, Yoshihiro Nakata

BRAIN RESEARCH (2016)

Article Clinical Neurology

Altered Serum Levels of Matrix Metalloproteinase-2,-9 in Response to Electroconvulsive Therapy for Mood Disorders

Chiyo Shibasaki, Minoru Takebayashi, Kei Itagaki, Hiromi Abe, Naoto Kajitani, Mami Okada-Tsuchioka, Shigeto Yamawaki

INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2016)

Article Biochemistry & Molecular Biology

Identification of Lysophosphatidic Acid Receptor 1 in Astroglial Cells as a Target for Glial Cell Line-derived Neurotrophic Factor Expression Induced by Antidepressants

Naoto Kajitani, Kanako Miyano, Mami Okada-Tsuchioka, Hiromi Abe, Kei Itagaki, Kazue Hisaoka-Nakashima, Norimitsu Morioka, Yasuhito Uezono, Minoru Takebayashi

JOURNAL OF BIOLOGICAL CHEMISTRY (2016)

Article Clinical Neurology

Possible Association between Serum Matrix Metalloproteinase-9 (MMP-9) Levels and Relapse in Depressed Patients following Electroconvulsive Therapy (ECT)

Chiyo Shibasaki, Kei Itagaki, Hiromi Abe, Naoto Kajitani, Mami Okada-Tsuchioka, Minoru Takebayashi

INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2018)

Article Clinical Neurology

Factors associated with relapse after a response to electroconvulsive therapy in unipolar versus bipolar depression

Kei Itagaki, Minoru Takebayashi, Chiyo Shibasaki, Naoto Kajitani, Hiromi Abe, Mami Okada-Tsuchioka, Shigeto Yamawaki

JOURNAL OF AFFECTIVE DISORDERS (2017)

Article Clinical Neurology

Reduced Serum and Cerebrospinal Fluid Levels of Autotaxin in Major Depressive Disorder

Kei Itagaki, Minoru Takebayashi, Hiromi Abe, Chiyo Shibasaki, Naoto Kajitani, Mami Okada-Tsuchioka, Kotaro Hattori, Sumiko Yoshida, Hiroshi Kunugi, Shigeto Yamawaki

INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2019)

Article Clinical Neurology

Shared preventive factors associated with relapse after a response to electroconvulsive therapy in four major psychiatric disorders

Wataru Omori, Kei Itagaki, Naoto Kajitani, Hiromi Abe, Mami Okada-Tsuchioka, Yasumasa Okamoto, Minoru Takebayashi

PSYCHIATRY AND CLINICAL NEUROSCIENCES (2019)

Article Biochemistry & Molecular Biology

Differential anatomical and cellular expression of lysophosphatidic acid receptor 1 in adult mouse brain

Naoto Kajitani, Mami Okada-Tsuchioka, Kuniyuki Kano, Wataru Omori, Shuken Boku, Junken Aoki, Minoru Takebayashi

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2020)

Article Clinical Neurology

Increased Matrix Metalloproteinases in Cerebrospinal Fluids of Patients With Major Depressive Disorder and Schizophrenia

Wataru Omori, Kotaro Hattori, Naoto Kajitani, Mami Okada-Tsuchioka, Shuken Boku, Hiroshi Kunugi, Yasumasa Okamoto, Minoru Takebayashi

INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2020)

Article Clinical Neurology

Reduced Cerebrospinal Fluid Levels of Lysophosphatidic Acid Docosahexaenoic Acid in Patients With Major Depressive Disorder and Schizophrenia

Wataru Omori, Kuniyuki Kano, Kotaro Hattori, Naoto Kajitani, Mami Okada-Tsuchioka, Shuken Boku, Hiroshi Kunugi, Junken Aoki, Minoru Takebayashi

Summary: The study found significantly lower levels of LPA 22:6 in patients with MDD and SCZ compared to healthy controls, with a negative correlation with clinical symptom scores in MDD patients. Additionally, the levels of LPA 22:6 were significantly correlated with LPC 22:6 levels among all 3 groups, but not with ATX activity in MDD and SCZ patients.

INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2021)

Article Biochemistry & Molecular Biology

Lysophosphatidic acid induces thrombospondin-1 production in primary cultured rat cortical astrocytes

Kazue Hisaoka-Nakashima, Toshiki Yokoe, Shintaro Watanabe, Yoki Nakamura, Naoto Kajitani, Mami Okada-Tsuchioka, Minoru Takebayashi, Yoshihiro Nakata, Norimitsu Morioka

Summary: The study demonstrates that LPA increases TSP-1 production in astrocytes through activation of LPA(1/3) receptors, involving Gi/o-coupled LPA(1) and LPA(3) receptors.

JOURNAL OF NEUROCHEMISTRY (2021)

Article Neurosciences

Decreased serum levels of thrombospondin-1 in female depressed patients

Mami Okada-Tsuchioka, Wataru Omori, Naoto Kajitani, Chiyo Shibasaki, Kei Itagaki, Minoru Takebayashi

NEUROPSYCHOPHARMACOLOGY REPORTS (2020)

Article Clinical Neurology

Associations of maternal prenatal psychological symptoms and saliva cortisol with neonatal meconium microbiota: A cross-sectional study

Nadia Deflorin, Ulrike Ehlert, Rita T. Amiel Castro

Summary: Changes in the gut microbiome of infants have been associated with maternal psychological symptoms during pregnancy. This study found that maternal prenatal depressive symptoms are associated with lower diversity of the infant's microbiome, while maternal saliva cortisol levels are linked to increased diversity and changes in specific bacterial groups. Further research is needed to understand the implications of these microbiota alterations for child health.

PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2024)

Article Clinical Neurology

Association between suicidal behavior and impaired glucose metabolism in first-episode drug-naive patients with schizophrenia

Zheng Ma, Hui-Xia Zhou, Da-Chun Chen, Dong-Mei Wang, Xiang-Yang Zhang

Summary: The impaired glucose metabolism in drug-na & iuml;ve schizophrenia patients is strongly associated with suicidal behavior, suggesting that glucose metabolism abnormalities may be potential biomarkers of suicide in schizophrenia patients. Regular monitoring of glucose metabolism variables is essential for suicide prevention.

PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2024)

Article Clinical Neurology

Transdiagnostic cognitive biases in psychiatric disorders: A systematic review and network meta-analysis

Katie M. Lavigne, Jiaxuan Deng, Delphine Raucher-Chene, Adele Hotte-Meunier, Chloe Voyer, Lisa Sarraf, Martin Lepage, Genevieve Sauve

Summary: Psychiatric disorders are characterized by cognitive deficits and cognitive biases, which are associated with specific symptoms. While cognitive biases are present across diagnoses, their severity varies.

PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2024)

Article Clinical Neurology

Gamma oscillations in the mPFC: A potential predictive biomarker of depression and antidepressant effects

Yong-Yu Yin, Jiao-Zhao Yan, Shi-Xin Lai, Qian-Qian Wei, Si-Rui Sun, Li-Ming Zhang, Yun-Feng Li

Summary: This study found that gamma oscillations are closely associated with depression and may serve as predictive biomarkers of depression. Chronic restraint stress and lipopolysaccharide induced significant depression-like behaviors in mice and reduced gamma oscillations in the medial prefrontal cortex. Administration of ketamine, scopolamine, or fluoxetine increased gamma oscillations and exhibited rapid-acting antidepressant effects.

PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2024)

Article Clinical Neurology

Transcriptomic analyses of rats exposed to chronic mild stress: Modulation by chronic treatment with the antipsychotic drug lurasidone

Veronica Begni, Moira Marizzoni, Kerstin Camile Creutzberg, Diana Morena Silipo, Mariusz Papp, Annamaria Cattaneo, Marco Andrea Riva

Summary: Exposure to stressful experiences is a significant risk factor for mental disorders, and pharmacological interventions targeting stress-induced alterations can help restore brain function. Lurasidone, an antipsychotic drug, has been shown to normalize the impairments caused by stress exposure and could be a valuable treatment for stress-induced mental illnesses. However, the mechanisms underlying the therapeutic effects of lurasidone are not well understood. This study found that chronic lurasidone treatment counteracted some of the transcriptional changes induced by chronic mild stress exposure, providing new insights into the potential therapeutic effects of lurasidone.

PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2024)

Article Clinical Neurology

Early life interpersonal stress and depression: Social reward processing as a potential mediator

Esther E. Palacios-Barrios, Kunal Patel, Jamie L. Hanson

Summary: This review examines the association between early life interpersonal stress (ELIS) and depression, as well as the underlying mechanisms. The research shows that ELIS affects how youth respond to social rewards, and similar impairments in social reward processing are observed in youth with depression. The authors propose a preliminary model that suggests neurobehavioral disruptions in social reward processing as a mediating factor in the connection between ELIS and depression.

PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2024)

Article Clinical Neurology

Metabolomics and transcriptomics analysis of prefrontal cortex in the Pax2 neuron-specific deletion mice

Rui Li, Jiaming Tang, Yizhuo Wang, Ying Wang, Hua Yang, Hongen Wei

Summary: Restricted and repetitive behaviors (RRBs) are characteristic features of neuropsychiatric disorders. This study focused on repetitive self-grooming behavior and investigated the involvement of the Pax2 gene in its control. Through the use of Pax2 neuron-specific deletion mice, the study found that the deletion of Pax2 gene affects the expression of the Arc gene in the prefrontal cortex, leading to impaired synaptic plasticity and excitatory/inhibitory imbalance, thereby contributing to the occurrence of repetitive self-grooming behavior.

PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2024)

Article Clinical Neurology

Changes in neurotrophic signaling pathways in brain areas of the chronic mild stress rat model of depression as a signature of ketamine fast antidepressant response/non-response

Sara Derosa, Paulina Misztak, Jessica Mingardi, Giulia Mazzini, Heidi Kaastrup Muller, Laura Musazzi

Summary: This study investigated the involvement of neurotrophic signaling pathways in stress vulnerability/resilience and fast antidepressant response/non-response to ketamine in a rat model of depression. The findings showed that stress and ketamine induced specific changes in these pathways in different brain areas and subcellular fractions.

PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2024)

Review Clinical Neurology

To what extent does white matter map to cognition in bipolar disorder? A systematic review of the evidence

Georgia F. Caruana, Sean P. Carruthers, Michael Berk, Susan L. Rossell, Tamsyn E. Van Rheenen

Summary: Cognitive impairment is related to both white matter macrostructure and microstructure in bipolar disorder patients. However, there is inconsistency in the results of the studies examining this relationship. Some studies have found an association between higher fractional anisotropy in white matter and better complex attention skills and executive functioning in bipolar disorder patients, while others have found no associations. Further research with increased statistical power and standardized methods is needed.

PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2024)

Review Clinical Neurology

Effectiveness of rTMS and tDCS treatment for chronic TBI symptoms: A systematic review and meta-analysis

Alberto Galimberti, Martin Tik, Giovanni Pellegrino, Anna-Lisa Schuler

Summary: This study provides a systematic review and meta-analysis on the effectiveness of repetitive transcranial magnetic stimulation (TMS) and transcranial direct current stimulation (tDCS) for post-traumatic brain injury (TBI) symptoms. The results show that non-invasive brain stimulation techniques have a small overall effect on TBI sequelae, with significant effects observed for anxiety and headache. However, larger randomized controlled trials with longer follow-ups, optimized stimulation parameters, and standardized methodology are needed to establish the efficacy of these techniques in addressing TBI sequelae.

PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2024)

Article Clinical Neurology

Doxycycline diminishes the rewarding and psychomotor effects induced by morphine and cocaine

Amanda J. Sales, Pedro H. Gobira, Joa F. C. Pedrazzi, Joao R. Silveia, Elaine Del Bel, Felipe V. Gomes, Francisco S. Guimaraes

Summary: The study found that doxycycline can inhibit metalloproteinase in the brain and attenuate the rewarding effects and locomotor sensitization of drug abuse. This suggests that doxycycline could be repurposed for the treatment of substance use disorders.

PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2024)

Article Clinical Neurology

An updated overview on the relationship between human gut microbiome dysbiosis and psychiatric and psychological disorders

Alejandro Borrego-Ruiz, Juan J. Borrego

Summary: There is substantial evidence that the development of the nervous system is related to the composition and functions of the gut microbiome. The communication between the central nervous system (CNS) and the gut microbiota is bidirectional, with various routes such as immune, endocrine, and neural circuits. Dysbiosis of the gut microbiota has been associated with neuropsychiatric diseases and psychological disorders. Fecal microbiota transplantation (FMT) therapy has shown a causal-effect relationship between the gut microbiota and behavioral features. Interventions based on prebiotics, probiotics, or synbiotics have demonstrated their influence on neurological disorders through the synthesis of neuroactive compounds and regulation of inflammatory and endocrine processes. Further research is needed to explore the impact of gut microbiota dysbiosis on psychiatric and psychological disorders and the potential therapeutic role of microbiota-based interventions.

PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2024)

Article Clinical Neurology

Associations of resilience, white matter topological organization, and cognitive functions in first-episode, drug-naive schizophrenia patients: A moderated mediation analysis

Zhinan Li, Zhuang Kang, Xiaowei Xia, Leijun Li, Junyan Wu, Jiamin Dai, Tong Liu, Cai Chen, Yong Qiu, Ming Chen, Yanxi Liu, Ziyi Zhang, Zili Han, Zhengjia Dai, Qinling Wei

Summary: This study found that patients with schizophrenia showed lower levels of resilience and cognitive functions compared to healthy controls, as well as abnormal global properties and nodal metrics in brain networks. Furthermore, characteristic path length might moderate the relationship between resilience and working memory in these patients.

PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2024)

Article Clinical Neurology

Executive functioning trajectories and their prospective association with inflammatory biomarkers in schizophrenia and non-psychiatric comparison participants

David H. Adamowicz, Tsung-Chin Wu, Rebecca Daly, Michael R. Irwin, Dilip Jeste, Xin M. Tu, Lisa T. Eyler, Ellen E. Lee

Summary: This study aimed to explore the relationship between executive functioning and inflammatory biomarkers in people with schizophrenia. The results showed that systemic inflammation did not predict long-term declines in executive functioning. This suggests the need for further research to better understand the relationship and mechanisms between inflammation and cognition in schizophrenia.

PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2024)

Article Clinical Neurology

A multivariate cognitive approach to predict social functioning in recent onset psychosis in response to computerized cognitive training

Nina Walter, Julian Wenzel, Shalaila S. Haas, Letizia Squarcina, Carolina Bonivento, Anne Ruef, Dominic Dwyer, Theresa Lichtenstein, Oeznur Bastruek, Alexandra Stainton, Linda A. Antonucci, Paolo Brambilla, Stephen J. Wood, Rachel Upthegrove, Stefan Borgwardt, Rebekka Lencer, Eva Meisenzahl, Raimo K. R. Salokangas, Christos Pantelis, Alessandro Bertolino, Nikolaos Koutsouleris, Joseph Kambeitz, Lana Kambeitz-Ilankovic

Summary: Clinical and neuroimaging data can be used to predict the potential of cognitive training to improve social functioning in recent onset psychosis patients. The use of multivariate pattern analysis and support vector machine classifier allows for the prediction of social functioning improvement based on baseline cognitive data. The findings suggest that cognitive data can provide a robust individual estimate of future social functioning for patients with recent onset psychosis.

PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2024)